Cargando…
Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality
This study aimed to determine the efficacy of Inoserp, Vins bioproducts, and South African Institute of Medical Research (SAIMR) polyvalent antivenoms in neutralizing Naja ashei venom-induced lethality in mice. The neutralization efficacy of the antivenoms were expressed as effective dose, median ef...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065424/ https://www.ncbi.nlm.nih.gov/pubmed/35518711 http://dx.doi.org/10.1016/j.toxcx.2022.100124 |
_version_ | 1784699584742686720 |
---|---|
author | Okumu, Mitchel Otieno Mbaria, James Mucunu Gikunju, Joseph Kangangi Mbuthia, Paul Gichohi Madadi, Vincent Odongo Ochola, Francis Okumu Maloba, Kenneth Narotso Nderitu, Joseph Gichuki |
author_facet | Okumu, Mitchel Otieno Mbaria, James Mucunu Gikunju, Joseph Kangangi Mbuthia, Paul Gichohi Madadi, Vincent Odongo Ochola, Francis Okumu Maloba, Kenneth Narotso Nderitu, Joseph Gichuki |
author_sort | Okumu, Mitchel Otieno |
collection | PubMed |
description | This study aimed to determine the efficacy of Inoserp, Vins bioproducts, and South African Institute of Medical Research (SAIMR) polyvalent antivenoms in neutralizing Naja ashei venom-induced lethality in mice. The neutralization efficacy of the antivenoms were expressed as effective dose, median effective ratio, potency, normalized potency, volume, and the number of vials of antivenom required to neutralize 100 mg of Naja ashei venom (NAV). |
format | Online Article Text |
id | pubmed-9065424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90654242022-05-04 Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality Okumu, Mitchel Otieno Mbaria, James Mucunu Gikunju, Joseph Kangangi Mbuthia, Paul Gichohi Madadi, Vincent Odongo Ochola, Francis Okumu Maloba, Kenneth Narotso Nderitu, Joseph Gichuki Toxicon X Clinical studies, antivenoms and epidemiology This study aimed to determine the efficacy of Inoserp, Vins bioproducts, and South African Institute of Medical Research (SAIMR) polyvalent antivenoms in neutralizing Naja ashei venom-induced lethality in mice. The neutralization efficacy of the antivenoms were expressed as effective dose, median effective ratio, potency, normalized potency, volume, and the number of vials of antivenom required to neutralize 100 mg of Naja ashei venom (NAV). Elsevier 2022-04-27 /pmc/articles/PMC9065424/ /pubmed/35518711 http://dx.doi.org/10.1016/j.toxcx.2022.100124 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Clinical studies, antivenoms and epidemiology Okumu, Mitchel Otieno Mbaria, James Mucunu Gikunju, Joseph Kangangi Mbuthia, Paul Gichohi Madadi, Vincent Odongo Ochola, Francis Okumu Maloba, Kenneth Narotso Nderitu, Joseph Gichuki Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality |
title | Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality |
title_full | Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality |
title_fullStr | Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality |
title_full_unstemmed | Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality |
title_short | Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality |
title_sort | preclinical efficacy testing of three antivenoms against naja ashei venom-induced lethality |
topic | Clinical studies, antivenoms and epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065424/ https://www.ncbi.nlm.nih.gov/pubmed/35518711 http://dx.doi.org/10.1016/j.toxcx.2022.100124 |
work_keys_str_mv | AT okumumitchelotieno preclinicalefficacytestingofthreeantivenomsagainstnajaasheivenominducedlethality AT mbariajamesmucunu preclinicalefficacytestingofthreeantivenomsagainstnajaasheivenominducedlethality AT gikunjujosephkangangi preclinicalefficacytestingofthreeantivenomsagainstnajaasheivenominducedlethality AT mbuthiapaulgichohi preclinicalefficacytestingofthreeantivenomsagainstnajaasheivenominducedlethality AT madadivincentodongo preclinicalefficacytestingofthreeantivenomsagainstnajaasheivenominducedlethality AT ocholafrancisokumu preclinicalefficacytestingofthreeantivenomsagainstnajaasheivenominducedlethality AT malobakennethnarotso preclinicalefficacytestingofthreeantivenomsagainstnajaasheivenominducedlethality AT nderitujosephgichuki preclinicalefficacytestingofthreeantivenomsagainstnajaasheivenominducedlethality |